Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Site Map
2021
January
21
Qiagen plans FDA resubmission of coronavirus rapid antigen test
Illumina claims another win in BGI patent dispute, this time in U.K.
CMS rejects Epi proColon payments, sets standards for cancer blood tests
HHS outsources review of some lab-developed COVID-19 tests
Page 1 of 1